Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature

Health Economics (United Kingdom)

Volumn 25, Issue , 2016, Pages 9-28

  Pitt, Catherine ^a   Goodman, Catherine ^a   Hanson, Kara ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

bibliometrics; cost effectiveness analysis; economic evaluation; high income countries; low income countries; middle income countries

Indexed keywords

ARTICLE; BIBLIOMETRICS; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEVELOPING COUNTRY; ECONOMIC EVALUATION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; RESEARCH PRIORITY; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; COST BENEFIT ANALYSIS; DEVELOPED COUNTRY; ECONOMICS; FACTUAL DATABASE; GLOBAL HEALTH; HEALTH SERVICES RESEARCH;

BIBLIOMETRICS; COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; ECONOMICS, MEDICAL; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS;

EID: 84956586707     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.3305     Document Type: Article

References (62)

1. Aksnes DW, Schneider JW, Gunnarsson M,. 2012. Ranking national research systems by citation indicators: a comparative analysis using whole and fractionalised counting methods. Journal of Informetrics 6: 36-43.
2. Augustovski F, Iglesias C, Manca A, Drummond M, Rubinstein A, Marti SG,. 2009. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region. PharmacoEconomics 27: 919-29.
3. Bartram J, Lewis K, Lenton R, Wright A,. 2005. Focusing on improved water and sanitation for health. Lancet 365: 810-2.
4. Byass P, De Courten M, Graham WJ, Laflamme L, Mccaw-Binns A, Sankoh OA, Tollman SM, Zaba B,. 2013. Reflections on the global burden of disease 2010 estimates. PLoS Medicine 10: e1001477.
5. Chao TE, Sharma K, Mandigo M, Hagander L, Resch SC, Weiser TG, Meara JG,. 2014. Cost-effectiveness of surgery and its policy implications for global health: a systematic review and analysis. The Lancet Global Health 2: e334-e345.
6. Chavan S, Newlands D, Smith C,. 2011. A Systematic Review of Economic Evaluations of Chemoprophylaxis for Tuberculosis, Journal of Tropical Medicine.
7. Chu KM, Jayaraman S, Kyamanywa P, Ntakiyiruta G,. 2014. Building research capacity in Africa: equity and global health collaborations. PLoS Medicine 11: e1001612.
8. Creese A, Floyd K, Alban A, Guinness L,. 2002. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359: 1635-43.
9. Cunnama, L., Sinanovic, E., Ramma, L., Foster, N., Berrie, L., Stevens, W., Molapo, S., Marokane, P., Mccarthy, K., Churchyard, G., &, Vassall, A., 2016. Using top-down and bottom-up costing approaches in LMICs: The case for using both to assess the incremental costs of new technologies at scale. Health Economics 25: S1, DOI: 10.1002/hec.3295.
10. Dakin H, Wordsworth S,. 2013. Cost-minimisation analysis versus cost-effectiveness analysis, revisited. Health Economics 22: 22-34.
11. Drummond M, Weatherly H, Ferguson B,. 2008. Economic evaluation of health interventions. BMJ 337: a1204.
12. Drummond MF, Sculpher MJ, Torrance GW, O'brien BJ, Stoddart GL,. 2005. Methods for the economic evaluation of health care programmes, Oxford, Oxford University Press.
13. Fesenfeld M, Hutubessy R, Jit M,. 2013. Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. Vaccine 31: 3786-3804.
14. Fitzpatrick C, Floyd K,. 2012. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. PharmacoEconomics 30: 63-80.
15. Galarraga O, Colchero MA, Wamai RG, Bertozzi SM,. 2009. HIV prevention cost-effectiveness: a systematic review. BMC Public Health 9 (1)Suppl: S5.
16. Gavaza P, Rascati KL, Oladapo AO, Khoza S,. 2010. The state of health economic evaluation research in Nigeria: a systematic review. PharmacoEconomics 28: 539-53.
17. Geroy LSA,. 2012. Economic evaluation for first-line anti-hypertensive medicines: Applications for the Philippines. Cost Effectiveness and Resource Allocation 10.
18. Goodman CA, Mills AJ,. 1999. The evidence base on the cost-effectiveness of malaria control measures in Africa. Health Policy and Planning 14: 301-12.
19. Greco, G., Lorgelly, P., &, Yamabhai, I., 2016. Outcomes in economic evaluations of public health interventions in low- and middle-income countries: health, capabilities and subjective wellbeing. Health Economics 25: S1, DOI: 10.1002/hec.3302.
20. Greenberg D, Rosen AB, Wacht O, Palmer J, Neumann PJ,. 2010. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006. Medical Decision Making 30: 320-327.
21. Griffiths U, Legood R, Pitt C,. 2016. Comparison of Economic Evaluation Methods Across Low-income, Middle-income, and High-Income Countries: What Are the Differences and Why?. Health Economics 25: S1, DOI: 10.1002/hec.3312.
22. Griffiths UK, Miners A,. 2009. Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature. Expert Review of Pharmacoeconomics and Outcomes Research 9: 333-346.
23. Hagen NT,. 2013. Harmonic coauthor credit: a parsimonious quantification of the byline hierarchy. Journal of Informetrics 7: 784-791.
24. Johri M, Ako-Arrey D,. 2011. The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review. Cost Effectiveness and Resource Allocation 9.
25. Kaló Z, Gheorghe A, Huic M, Csanadi M, Boerlum Kristensen F,. 2016. HTA Implementation Roadmap in Central and Eastern European Countries. Health Economics 25: S1, DOI: 10.1002/hec.3298.
26. Kerber KJ, De Graft-Johnson JE, Bhutta ZA, Okong P, Starrs A, Lawn JE,. 2007. Continuum of care for maternal, newborn, and child health: from slogan to service delivery. Lancet 370: 1358-69.
27. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D,. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 62: e1-34.
28. Mangham-Jefferies L, Pitt C, Cousens S, Mills A, Schellenberg J,. 2014. Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review. BMC Pregnancy and Childbirth 14: 243.
29. Mcintyre D, Wayling S, WORLD HEALTH ORGANIZATION & SPECIAL PROGRAMME FOR RESEARCH AND TRAINING IN TROPICAL DISEASES. 2008. Strengthening health-economics capability in Africa: summary and outcomes of a regional consultation of experts and policy-makers, Geneva, World Health Organization/Special Programme for Research & Training in Tropical Diseases.
30. Mills AJ, Thomas M,. 1984. Economic Evaluation of Health Programmes in Developing Countries: A review and selected annotated bibliography, London: London School of Hygiene & Tropical Medicine.
31. Mori AT, Robberstad B,. 2012. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and Decision Making 12.
32. Mulligan JA, Walker D, Fox-Rushby J,. 2006. Economic evaluations of non-communicable disease interventions in developing countries: a critical review of the evidence base. Cost Eff Resour Alloc 4: 7.
33. Natunen K, Lehtinen TA, Torvinen S, Lehtinen M,. 2013. Cost-effectiveness of HPV-vaccination in medium or low income countries with high cervical cancer incidence-a systematic review. Journal of Vaccines and Vaccination 4: 172.
34. Nord E,. 2013. Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement. Health Policy 111: 99-104.
35. Odame EA,. 2013. Systematic review of economic evaluation literature in Ghana: is health technology assessment the future? Value in Health Regional Issues 2: 279-283.
36. Ott JJ, Breteler JK, Tam JS, Hutubessy RCW, Jit M, De Boer MR,. 2013. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Human Vaccines and Immunotherapeutics 9: 1500-1511.
37. Pawlowski A, Jansson M, Sköld M, Rottenberg ME, Källenius G,. 2012. Tuberculosis and HIV co-infection. PLoS Pathogens 8.
38. Perez Velasco R, Praditsitthikorn N, Wichmann K, Mohara A, Kotirum S, Tantivess S, Vallenas C, Harmanci H, Teerawattananon Y,. 2012. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics. PLoS One 7: e30333.
39. Pritchard A,. 1969. Statistical bibliography or bibliometrics. Journal of Documentation 25: 348-349.
40. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S,. 2005. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value in Health 8: 521-33.
41. Retzer V, Jurasinski G,. 2009. Towards objectivity in research evaluation using bibliometric indicators-a protocol for incorporating complexity. Basic and Applied Ecology 10: 393-400.
42. Rubin RM, Chang CF,. 2003. A bibliometric analysis of health economics articles in the economics literature: 1991-2000. Health Economics 12: 403-414.
43. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, Karyana M, Kosen S, Farje MR, Moncada G, Dutta A, Sazawal S, Dyer A, Seiler J, Aboyans V, Baker L, Baxter A, Benjamin EJ, Bhalla K, Abdulhak AB, Blyth F, Bourne R, Braithwaite T, Brooks P, Brugha TS, Bryan-Hancock C, Buchbinder R, Burney P, Calabria B, Chen H, Chugh SS, Cooley R, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, Davis A, Degenhardt L, Díaz-Torné C, Dorsey ER, Driscoll T, Edmond K, Elbaz A, Ezzati M, Feigin V, Ferri CP, Flaxman AD, Flood L, Fransen M, Fuse K, Gabbe BJ, Gillum RF, Haagsma J, Harrison JE, Havmoeller R, Hay RJ, Hel-Baqui A, Hoek HW, Hoffman H, Hogeland E, Hoy D, Jarvis D, Jonas JB, Karthikeyan G, Knowlton LM, Lathlean T, Leasher JL, Lim SS, Lipshultz SE, Lopez AD, Lozano R, Lyons R, Malekzadeh R, Marcenes W, March L, Margolis DJ, Mcgill N, Mcgrath J, Mensah GA, Meyer AC, Michaud C, Moran A, Mori R, Murdoch ME, Naldi L, Newton CR, Norman R, Omer SB, Osborne R, Pearce N, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Pourmalek F, Prince M, Rehm JT, Remuzzi G, et al,. 2012. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet 380: 2129-2143.
44. Shroufi A, Chowdhury R, Anchala R, Stevens S, Blanco P, Han T, Niessen L, Franco OH,. 2013. Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review. BMC Public Health 13: 285.
45. Suhrcke M, Boluarte TA, Niessen L,. 2012. A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countries. BMC Public Health 12: 2.
46. Sweeney, S., Vassall, A., Foster, N., Simms, V., Ilboudo, P., Kimaro, G., Mudzengi, D., &, Guinness, L., 2016. Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income Countries. Health Economics 25: S1, DOI: 10.1002/hec.3304.
47. Teerawattananon Y, Russell S, Mugford M,. 2007. A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers? PharmacoEconomics 25: 467-479.
48. Valencia-Mendoza A, Danese-dlSantos LG, Sosa-Rubi SG, Aracena-Genao B,. 2011. Cost-effectiveness of public health practices: a literature review of public health interventions from the Mesoamerican Health Initiative. Salud Pública de México 53 (3)Suppl: S375-85.
49. Vassall A, Mangham-Jefferies L, Gomez GB, Pitt C, Foster N,. 2016. Incorporating Demand and Supply Constraints into Economic Evaluation in Low-Income and Middle-Income countries. Health Economics 25: S1, DOI: 10.1002/hec.3306.
50. Wagstaff A, Culyer AJ,. 2012. Four decades of health economics through a bibliometric lens. Journal of Health Economics 31: 406-439.
51. Walensky RP, Ciaranello AL, Park JE, Freedberg KA,. 2010. Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature. Clinical Infectious Diseases 51: 85-92.
52. Walker D, Fox-Rushby JA,. 2000. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Economics 9: 681-98.
53. Waters HR, Hyder AA, Phillips TL,. 2004. Economic evaluation of interventions to reduce road traffic injuries - a review of the literature with applications to low and middle-income countries. Asia-Pacific Journal of Public Health 16: 23-31.
54. White MT, Conteh L, Cibulskis R, Ghani AC,. 2011. Costs and cost-effectiveness of malaria control interventions-a systematic review. Malaria Journal 10: 337.
55. WHO GLOBAL MALARIA PROGRAMME. 2014. World malaria report 2014, Geneva, Switzerland: World Health Organization.
56. Wiseman V, Mitton C, Doyle-Waters M, Drake T, Conteh L, Newall AT, Onwujekwe O, Stephen J,. 2016. Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle Income Countries: A Systematic Review of Methodological Frameworks. Health Economics 25: S1, DOI: 10.1002/hec.3299.
57. WORLD BANK. 2015. Country and Lending Groups, World Bank Group: Washington, D.C.: World Bank Group.
58. WORLD HEALTH ORGANIZATION. 2011. International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Edition 2010, Geneva: World Health Organization.
59. WORLD HEALTH ORGANIZATION. 2012. Strategy on Health Policy and Systems Research: Changing Mindsets, Geneva, World Health Organization.
60. WORLD HEALTH ORGANIZATION. 2013. Global Status Report on Road Safety 2013: Supporting a Decade of Action, Geneva: World Health Organization.
61. WORLD HEALTH ORGANIZATION. 2014. Global Health Estimates 2014 Summary Tables: DALY by Cause, Age and Sex, by World Bank Income Group Category, 2000-2012, Geneva: World Health Organization.
62. Zumla A, Al-Tawfiq JA, Enne VI, Kidd M, Drosten C, Breuer J, Muller MA, Hui D, Maeurer M, Bates M, Mwaba P, Al-Hakeem R, Gray G, Gautret P, Al-Rabeeah AA, Memish ZA, Gant V,. 2014. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections - needs, advances, and future prospects. Lancet Infectious Diseases 14: 1123-35.